112 related articles for article (PubMed ID: 12073267)
1. [Therapeutic policy in stage I-II laryngeal cancer].
Amiraliev NM
Lik Sprava; 2002; (2):72-6. PubMed ID: 12073267
[TBL] [Abstract][Full Text] [Related]
2. Exclusive radiotherapy for stage T1-T2N0M0 lanryngeal cancer: retrospective study of 59 patients at CFB and CHU de Caen.
Cuny F; Géry B; Florescu C; Clarisse B; Blanchard D; Rame JP; Babin E; De Raucourt D
Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Nov; 130(5):251-6. PubMed ID: 23759281
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up and salvage surgery in patients with T2N0M0 squamous cell carcinoma of the glottic larynx following concurrent chemoradiation therapy with cisplatin and 5-fluorouracil for laryngeal preservation.
Furusaka T; Susaki Y; Saito T; Katsura Y; Ikeda M
Acta Otolaryngol; 2013 Jan; 133(1):91-8. PubMed ID: 23106387
[TBL] [Abstract][Full Text] [Related]
4. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
[TBL] [Abstract][Full Text] [Related]
5. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
6. Concurrent chemoradiation therapy with docetaxel (DOC) for laryngeal preservation in T2N0M0 glottic squamous cell carcinomas.
Furusaka T; Matsuda A; Saito T; Katsura Y; Ikeda M
Acta Otolaryngol; 2013 Jan; 133(1):99-112. PubMed ID: 23106412
[TBL] [Abstract][Full Text] [Related]
7. Treatment, comorbidity and survival in stage III laryngeal cancer.
Connor KL; Pattle S; Kerr GR; Junor E
Head Neck; 2015 May; 37(5):698-706. PubMed ID: 24596316
[TBL] [Abstract][Full Text] [Related]
8. Results of 226 patients with T3 laryngeal carcinoma after treatment with transoral laser microsurgery.
Canis M; Ihler F; Martin A; Wolff HA; Matthias C; Steiner W
Head Neck; 2014 May; 36(5):652-9. PubMed ID: 23596018
[TBL] [Abstract][Full Text] [Related]
9. Multimodal treatment for t1-2 supraglottic cancer: the impact of tumor location.
Suzuki G; Yamazaki H; Ogo E; Abe T; Hayabuchi N; Umeno H; Nakashima T; Nakamura S; Yoshida K
Anticancer Res; 2014 Jan; 34(1):203-7. PubMed ID: 24403463
[TBL] [Abstract][Full Text] [Related]
10. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
11. Management of T3N1 glottic carcinoma: therapeutic outcomes.
Spector JG; Sessions DG; Lenox J; Simpson J
Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
[TBL] [Abstract][Full Text] [Related]
12. Supraglottic laryngeal cancer: analysis of treatment results.
Sessions DG; Lenox J; Spector GJ
Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
[TBL] [Abstract][Full Text] [Related]
13. Survival Outcomes in Patients with T2N0M0 (Stage II) Squamous Cell Carcinoma of the Larynx.
Gainor DL; Marchiano E; Bellile E; Spector ME; Taylor JMG; Wolf GT; Hogikyan ND; Prince ME; Bradford CR; Eisbruch A; Worden F; Shuman AG
Otolaryngol Head Neck Surg; 2017 Oct; 157(4):625-630. PubMed ID: 28608731
[TBL] [Abstract][Full Text] [Related]
14. Predictors of outcome for advanced-stage supraglottic laryngeal cancer.
Ganly I; Patel SG; Matsuo J; Singh B; Kraus DH; Boyle J; Wong RJ; Lee N; Pfister DG; Shaha AR; Shah JP
Head Neck; 2009 Nov; 31(11):1489-95. PubMed ID: 19408292
[TBL] [Abstract][Full Text] [Related]
15. The effect of treatment on survival in patients with advanced laryngeal carcinoma.
Gourin CG; Conger BT; Sheils WC; Bilodeau PA; Coleman TA; Porubsky ES
Laryngoscope; 2009 Jul; 119(7):1312-7. PubMed ID: 19444887
[TBL] [Abstract][Full Text] [Related]
16. Factors leading to the use of alternate treatment modalities following transoral laser excision of T1 and T2 glottic squamous cell carcinoma.
Pham TA; De Freitas R; Sigston E; Vallance N
ANZ J Surg; 2012 Oct; 82(10):720-3. PubMed ID: 22901105
[TBL] [Abstract][Full Text] [Related]
17. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
[TBL] [Abstract][Full Text] [Related]
18. Glottic carcinomas: a retrospective study of 101 cases.
Broniatowski M
Ear Nose Throat J; 1985 Nov; 64(11):527-31. PubMed ID: 4064984
[No Abstract] [Full Text] [Related]
19. Survival outcomes in advanced laryngeal cancer.
Megwalu UC; Sikora AG
JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):855-60. PubMed ID: 25144163
[TBL] [Abstract][Full Text] [Related]
20. Superselective intra-arterial chemoradiation therapy for functional laryngeal preservation in advanced squamous cell carcinoma of the glottic larynx.
Furusaka T; Matsuda A; Tanaka A; Matsuda H; Ikeda M
Acta Otolaryngol; 2013 Jun; 133(6):633-40. PubMed ID: 23394224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
